U.S. Election Finance Reform Sought By End Citizens United

The End Citizens United group appears to be growing in supporters and political influence after being formed in 2015 with a limited aim of overturning the politically divisive issue of unlimited campaign funding that has blighted U.S. election cycles since it was introduced by the Supreme Court in 2010. The group has targeted the influence on elections of major donors, such as the Koch Brothers who have used their personal fortunes to support candidates who reflect their own beliefs, and in the view of End Citizens United are changing the policies of candidates who are battling to receive the patronage of these wealthy business people.


The short lifespan of the End Citizens United group has seen a huge level of funding flood into the organization to show just how dissatisfied the people of the U.S. have become with outside influences influencing major elections. During the 2016 election cycle the group raised around $25 million in its bid to raise awareness of the campaign finance issue and provide support for candidates who are friendly to the cause of campaign finance reform; this dedicated push to have a greater influence on the issue of campaign finances has seen End Citizens United become more involved with upcoming midterm elections in 2018, for which they hope to raise an impressive $35 million.


Average contributions towards End Citizens United have reached around $12 and upwards of $4 million had been donated by over 100,000 supporters during the first three months of 2017. Not only is the number of donors impressive over the short period of time in 2017, but the fact an estimated 40,000 donors had provided monetary support to End Citizens United for the first time has given fresh impetus to the group as they feel this level of first time support reflects the anger felt by everyday Americans across the nation.


The campaign materials of the End Citizens United PAC explain the major issue they are attempting to address is the political frustration many U.S. citizens feel as wealthy donors have taken the majority of power away from the average U.S. voter. Overturning the Citizens United Supreme court decision is no simple task and will involve gaining Congressional and state level support, which is why a major push has been made to back friendly candidates in midterms and special elections, such as the Congressional election in Georgia where End Citizens United hoped to raise $500,000 in support of a Democratic candidate in a traditionally Republican state. The decision to support Democrat’s was taken as the party and its politicians are more likely to support putting an end to the Citizens United decision, prompting End Citizens United to aim for $35 million in campaign contributions by the time of the 2018 midterm election cycle.


Betsy DeVos Is Jumping Right in As The Secretary of Education

When Betsy DeVos was nominated for the position of Secretary of Education, she faced a barrage of criticism about her policies of school choice and school vouchers. Her critics, largely coming from political opponents charged that she would want to destroy our present educational system and that she was a danger to our society.

Of course, that would be a disaster for anyone to try, as DeVos is a very concerned citizen regarding the state of our affairs concerning education. She has been a strong advocate of finding ways to serve better the inner city students as well as students in rural areas where funding is usually not as great as suburban schools.

Betsy DeVos operates with the same assumption that consumers do whenever they purchase any product. Rather than more choice resulting in the current public school model becoming destroyed, it should provide wider choices for parents and students regarding their education.

Read more: http://www.mlive.com/news/grand-rapids/index.ssf/2017/01/dick_and_betsy_devos_lift_the.html

When Uber and Lyft came out, offering ridesharing, the taxi companies had a fit, stating that it was unfair, but not mentioning that the Taxi companies have a monopoly in the larger cities where no new companies can ever start another taxi company. The same is true for the school districts.

DeVos asks the question to the point of why is it mandatory that students receive their education where quality is determined by the zip code in which they live? Would it not make more sense to give a quality education to students no matter where they live?

The technology that is available should be able to be applied to the problem. Most students already know how to operate a smartphone or a tablet, and there may not be a better device to use for delivering education than those types of products.

We are still using methods of educating our children that are the same as they were 400 years ago. The students are forced to come to a location and endure 4 or 5 30 minute lectures about subjects that are unconnected and have little or no meaning to the students. Why not rethink how students receive information and deliver it in the most meaningful way?

No one mandates that people take a Uber ride to the store, as there are many choices and people can usually decide for themselves how to handle most of their opportunities. DeVos has been very proactive in helping to set up and see first hand how school choice systems work.

She was very involved in the Detroit publically funded Charter School project that showed very promising results. Reading scores were way up, and so were graduation rates. This project took place over just a few years, but there was positive measured progress. This same idea is transferable and should be investigated more thoroughly. Visit dbdvfoundation.org to know more about their foundation.

The Functions of Oncotarget

Oncotarget is a medical journal with open access that is weekly peer-reviewed. The journal covers research on all issues concerning oncology. Oncotarget was started in 2010. The Impact Journals are its publishers. Mikhail Blagosklonny and Andrei Gudkov are both from the Roswell Park Cancer Institute. They serve as Oncotarget’s editors-in-chief. Oncotarget is a multidisciplinary journal. It publishes its papers online every week. Every article or issue can be printed in case a reader has a special demand. Oncotarget has been serving its readers with scientific research results for more than seven years. It has acquired a reputation as an efficient and reliable oncology journal.

The mission of Oncotarget is to avail scientific results to their international readers rapidly. The Journal also uses insightful review so as to maximize the research impact. Oncotarget enables quick sharing of exceptional discoveries. The journal has helped to remove the border that has been in existence between specialties. Oncotarget aims to connect various biomedical science fields and to promote the applications of both clinical and basic science in battling the disease. Oncotarget is headed by some of the most prominent scientists in the world. The journal has assisted many researchers in contributing to the progress and growth of science. The ultimate goal of Oncotarget is to ensure that people live a life with no diseases. Learn more about Oncotarget at Bioxbio.com.

The Journal has managed to launch other sections apart from oncology because of the success that it has experienced over the years. These include cardiology, neuroscience, cell biology, endocrinology, all areas of pharmacology, metabolism, and many more topics. The journal encourages young scientists to send their papers and articles on scientific research. Oncotarget has risen in popularity among readers because of the constructive, insightful, and punctual release of scientific results. Four Oncotarget members won the breakthrough prize in 2013. These members include Alexander Varshavsky, Michael Hall, Stephen Elledge, and Bert Vogelstein.

Oncotarget is the sponsors of the Gordon Research Conference. The journal has an impact factor of 5.008. This is according to reports by the Journal Citation in 2012. The word Oncotarget encompasses all cellular functions, molecules, and pathways found in aging and cancer. Check Oncotarget journal at scimagojr.com